Drug Shortage Report for MINESTRIN 1/20
| Report ID | 130398 |
| Drug Identification Number | 00343838 |
| Brand name | MINESTRIN 1/20 |
| Common or Proper name | Minestrin |
| Company Name | ALLERGAN INC |
| Market Status | MARKETED |
| Active Ingredient(s) | NORETHINDRONE ACETATE ETHINYL ESTRADIOL |
| Strength(s) | 1MG 20MCG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 5x28 |
| ATC code | G03AA |
| ATC description | HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-01-01 |
| Actual start date | 2021-01-01 |
| Estimated end date | 2021-02-20 |
| Actual end date | 2021-02-05 |
| Shortage status | Resolved |
| Updated date | 2021-02-06 |
| Company comments | |
| Health Canada comments | |
| Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.